Literature DB >> 31187881

Regulation of immunity and allergy by helminth parasites.

Rick M Maizels1.   

Abstract

There is increasing interest in helminth parasite modulation of the immune system, both from the fundamental perspective of the "arms race" between host and parasite, and equally importantly, to understand if parasites offer new pathways to abate and control untoward immune responses in humans. This article reviews the epidemiological and experimental evidence for parasite down-regulation of host immunity and immunopathology, in allergy and other immune disorders, and recent progress towards defining the mechanisms and molecular mediators which parasites exploit in order to modulate their host. Among these are novel products that interfere with epithelial cell alarmins, dendritic cell activation, macrophage function and T-cell responsiveness through the promotion of an immunoregulatory environment. These modulatory effects assist parasites to establish and survive, while dampening immune reactivity to allergens, autoantigens and microbiome determinants.
© 2020 The Authors. Allergy Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  allergy treatment; basic mechanisms; parasites

Mesh:

Year:  2019        PMID: 31187881     DOI: 10.1111/all.13944

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   14.710


  27 in total

Review 1.  Disorders of the enteric nervous system - a holistic view.

Authors:  Beate Niesler; Stefanie Kuerten; I Ekin Demir; Karl-Herbert Schäfer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-01-29       Impact factor: 46.802

Review 2.  Microbial Dysbiosis Tunes the Immune Response Towards Allergic Disease Outcomes.

Authors:  Tracy Augustine; Manoj Kumar; Souhaila Al Khodor; Nicholas van Panhuys
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-01       Impact factor: 8.667

3.  Enteric pathogens induce tissue tolerance and prevent neuronal loss from subsequent infections.

Authors:  Tomasz Ahrends; Begüm Aydin; Fanny Matheis; Cajsa H Classon; François Marchildon; Gláucia C Furtado; Sérgio A Lira; Daniel Mucida
Journal:  Cell       Date:  2021-10-29       Impact factor: 41.582

Review 4.  Basophils in antihelminth immunity.

Authors:  Jianya Peng; Mark C Siracusa
Journal:  Semin Immunol       Date:  2021-11-21       Impact factor: 11.130

5.  The notable global heterogeneity in the distribution of COVID-19 cases and the association with pre-existing parasitic diseases.

Authors:  Taehee Chang; Bong-Kwang Jung; Jong-Yil Chai; Sung-Il Cho
Journal:  PLoS Negl Trop Dis       Date:  2022-10-10

Review 6.  Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis.

Authors:  El-Bdaoui Haddad; Sonya L Cyr; Kazuhiko Arima; Robert A McDonald; Noah A Levit; Frank O Nestle
Journal:  Dermatol Ther (Heidelb)       Date:  2022-05-21

Review 7.  Therapeutic Potential for Intractable Asthma by Targeting L-Type Amino Acid Transporter 1.

Authors:  Keitaro Hayashi; Osamu Kaminuma
Journal:  Biomolecules       Date:  2022-04-08

8.  Venestatin from parasitic helminths interferes with receptor for advanced glycation end products (RAGE)-mediated immune responses to promote larval migration.

Authors:  Daigo Tsubokawa; Taisei Kikuchi; Jae Man Lee; Takahiro Kusakabe; Yasuhiko Yamamoto; Haruhiko Maruyama
Journal:  PLoS Pathog       Date:  2021-06-03       Impact factor: 6.823

Review 9.  Harnessing helminth-driven immunoregulation in the search for novel therapeutic modalities.

Authors:  Stephanie M Ryan; Ramon M Eichenberger; Roland Ruscher; Paul R Giacomin; Alex Loukas
Journal:  PLoS Pathog       Date:  2020-05-14       Impact factor: 6.823

10.  Lack of Consistent Association between Asthma, Allergic Diseases, and Intestinal Helminth Infection in School-Aged Children in the Province of Bengo, Angola.

Authors:  Margarete Arrais; Ofélia Lulua; Francisca Quifica; José Rosado-Pinto; Jorge M R Gama; Philip J Cooper; Luis Taborda-Barata; Miguel Brito
Journal:  Int J Environ Res Public Health       Date:  2021-06-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.